South Korea · Health Care · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
5.37%
2025 (actual)
ROA
3.04%
2025 (actual)
Gross Margin
100%
2025 (actual)
Net Margin
3.98%
2025 (actual)
Total Assets
₩84,686.91M
2025 (actual)
Net Income
₩2,585.53M
2025 (actual)
Valuation
₩51,723.22M
2026 (forecast)
Stock Price
₩4,500
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-1.4 pt
Company
ROA
-1.1 pt
Company
Gross Margin
+0 pt
Company
Sector average
Net Margin
-1.6 pt
Company
Total Assets
+41.7%
Company
Sector average (own scale)
Net Income
-11.3%
Company
Valuation
+33.3%
Company
Sector average (own scale)
Stock Price
+33.3%
Company
Sector average (own scale)
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for C&R Research Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.